Filing Details
- Accession Number:
- 0001209191-23-015775
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 17:20:31
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 17:20:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Surgical & Medical Instruments & Apparatus (3841) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563606 | Jr. T. Robert Davis | 1100 Campus Road Princeton NJ 08540 | Evp & President, Tt | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-01 | 1,566 | $26.87 | 47,486 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-01 | 1,566 | $55.21 | 45,920 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-01 | 1,566 | $0.00 | 1,566 | $26.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-03-23 | No | 4 | M | Direct |
Footnotes
- The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $55.2118 to $55.22. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- 25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 03/23/2015.